Healthcare resource utilization and economic burden in generalized pustular psoriasis (GPP) among U.S. adults: A large claims database analysis
Generalized pustular psoriasis (GPP) is a chronic, systemic, and potentially life-threatening skin disease, characterized by flares of painful pustules and erythema, often accompanied by systemic symptoms.1,2 Patients have significantly more comorbidities (eg type 2 diabetes, psoriatic arthritis) and serious complications (eg sepsis) than those with plaque psoriasis (PsO), which is a clinically and pathologically distinct disease from GPP.3,4
Authors
- Layla Lavasani
- Mark Lebwohl (ORCID: https://orcid.org/0000-0002-4705-5303)
- Juan Semeco
- Bruce Strober
- Alice B. Gottlieb
- Bhargav Lakshminarasimhan
Institutions
- Boehringer Ingelheim (Germany) (DE)
- Yale University (US)
- Connecticut Mental Health Center (US)
- Icahn School of Medicine at Mount Sinai (US)
Publication Details
- Journal
- Journal of the American Academy of Dermatology
- Published
- 2025-07-24
- DOI
- https://doi.org/10.1016/j.jaad.2025.07.048
- Citations
- 1
- Primary Topic
- Psoriasis: Treatment and Pathogenesis
- Type
- article
- Field-Weighted Citation Impact
- 0.80
Funders
- Boehringer Ingelheim